baber/WOPTO huggingface dataset:
Patent FI-20020193-A0 (FI)
Inventor: JAERVINEN LASSI
IPC: B28B23/02
Filed: 2002-02-01
Abstract: A method and apparatus are disclosed for fabricating a concrete product in a slip-form casting process, in which method concrete mix is fed into a slip-form mold of a defined cross section moving progressively in the casting process so as to obtain a concrete product of a desired shape. The method is characterized by an interruptible guidance control of the prestressing tendons so as to allow the tendon guides to travel past supplementary parts such as reinforcing steels connected to the prestressing tendons. <IMAGE>
Patent FI-20030434-A0 (FI)
Inventor: KIVIRANTA VELI-MATTI
IPC: H04W64/00
Filed: 2003-03-24
Abstract: A location of a subscriber can be observed by means of a mobile network in a completely anonymous way, without a subscriber identifier or a temporary subscriber identifier. At first, a method extracts from a first time slot of a radio channel a message which includes information about a second time slot of a radio channel. The first time slot of a radio channel discloses the current cell of the subscriber and the second time slot of a radio channel discloses a new cell of the subscriber. A location of the subscriber is determined on the basis of the current and the new cell. This location is approximately situated in a geographical intersection area of the current and the new cell. Different kinds of statistics can be deduced from the observations concerning activities of subscribers.
Patent FI-20106154-A0 (FI)
Inventor: GYLLING KAI
IPC: E21B/
Filed: 2010-11-03
Abstract: A method for coupling an earth pipe into the ground when utilizing an apparatus that has a drilling device including a casing part and a drilling unit inside thereof. The drilling unit includes a first drilling member for drilling a center hole and a second drilling member for reaming the center hole for the casing part. The casing part is arranged to be drawn into the hole by the first and/or second drilling member. After drilling a hole for the earth pipe and lifting up the first drilling member, a solidifying mass is led to the bottom of the hole to couple the earth pipe to the surrounding ground. The solidifying mass is brought in the casing part utilizing a flow-through assembly at a lower end of the casing part into a space between an outer surface of the casing part and the hole. Also an apparatus operating.
Patent IL-102712-A0 (IL)
Title: Variety of bacillus thuringiensis,insecticide derived therefrom and dna encoding the insecticide
IPC: A01N63/50
Filed: 1992-08-03
Abstract: Bacillus thuringiensis serovar japonensis strain Buibui (FERM BP-3465) belonging to Bacillus thuringiensis serovar japonensis and capable of producing insecticidal toxin proteins to kill coleopterous larvae, and an insecticide containing, as an effective ingredient, the toxin proteins produced.
Patent IL-104425-A0 (IL)
Title: Reduction of the formaldehyde content in microcapsule formulations
IPC: B01J13/20
Filed: 1993-01-18
Abstract: A process is disclosed for the reduction of the formaldehyde content of a formulation of amino resin microcapsules which comprises treating the microcapsule formulation with from about 0.03 wt. % to about 0.75 wt. % of ammonia. Also disclosed are the microcapsules formed by the process.
Patent IL-107551-A0 (IL)
Title: Novel compounds useful as sweetening agents and their method of preparation
IPC: C07K1/113
Filed: 1993-11-10
Abstract: Lower alkyl esters of compounds of the formula   <IMAGE>   wherein Z is hydrogen or hydroxyl and R is a hydrocarbyl group optionally substituted by hydroxy and/or alkoxy group, are useful as sweetening agents.
Patent IL-109403-A0 (IL)
Title: Oral drug delivery compositions and methods
IPC: A61K39/395
Filed: 1994-04-22
Abstract: The present invention relates to an oral drug delivery system, and in particular to modified amino acids and modified amino acid derivatives for use as a delivery system of sensitive agents such as bioactive peptides. The modified amino acids and derivatives can form non-covalent mixtures with active biological agents and in an alternate embodiment can releasably carry active agents. Modified amino acids can also form durg containing microspheres. These mixtures are suitable for oral administration of biologically active agents to animals. Methods for the preparation of such amino acids are also disclosed.
Patent IL-126274-A0 (IL)
Title: Safety device for liquid aerating apparatus
IPC: F17C13/04
Filed: 1998-09-17
Abstract: A liquid aerating apparatus-in combination with a cylinder containing gas under pressure (53); a cylinder holder (30) for retaining a pressure gas cylinder; an aerating (61) head for retaining a bottle (63) which contains a liquid to be aerated; an intermediate chamber (38), for receiving gas discharged from the cylinder (531); a cylinder valve (32) for normally preventing discharge from the cylinder into the chamber and permitting it when desired; valve actuating means (17') which have an inactive position, in which they do not act on the cylinder valve, and an active position, in which they cause the cylinder valve to be opened and gas to be discharged from the cylinder to the intermediate chamber; gas conduit mans (20 connecting the intermediate chamber with the aerating head; and auxiliary valve means (39) for sealing off the intermediate chamber from the conduit means when the cylinder valve is not fully closed and the valve actuating means are in the inactive position. The auxiliary valve means comprises a control chamber (25), a plunger (42) sealing off the control chamber from the intermediate chamber when the valve actuating means are in the inactive position and permitting passage of gas from the intermediate chamber when the valve actuating means are in the active position.
Patent IL-131131-A0 (IL)
Title: Synthetic hiv gag genes
IPC: C07K14/16
Filed: 1998-02-03
Abstract: Synthetic DNA molecules encoding HIV gag and modifications of HIV gag are provided. The codons of the synthetic molecules are codons preferred by the projected host cell. The synthetic molecules may be used as a polynucleotide vaccine which provides effective immunoprophylaxis against HIV infection through stimulation of neutralizing antibody and cell-mediated immunity.
Patent IL-134880-A0 (IL)
Title: A method of diagnosis
IPC: G01N33/68
Filed: 1998-09-04
Abstract: The present invention relates generally to a method of diagnosing or predicting the development of lung damage and more particularly, to a method of diagnosing or predicting the development of alveolo-capillary membrane damage. The method of the present invention is useful inter alia for detecting lung damage or predicting the development of lung damage such as that caused by noxious agents or as an undesirable side effect resulting from exposure to a therapeutic agent and for monitoring the progress of lung damage.
Patent IL-139440-A0 (IL)
Title: Chemical oxidation of volatile organic compounds
IPC: B09C1/08
Filed: 1999-05-04
Abstract: Volatile organic compounds are removed from contaminated soil by introducing one or both a water soluble peroxygen compound, such as a persulfate, and a permanganate into the soil, either in situ or ex situ, in amounts and under conditions wherein both the soil oxidant demand is satisfied and volatile organic compounds in the soil are oxidized. In a preferred embodiment, when both are used the peroxygen satisfies the soil oxidant demand and the permanganate oxidizes the volatile organic compounds. Sodium persulfate is the preferred persulfate and potassium permanganate is the preferred permanganate. The persulfate and the permanganate may be added to the soil sequentially, or may be mixed together and added as an aqueous solution.
Patent IL-143339-A0 (IL)
Title: Litter apparatus
IPC: A01K1/01
Filed: 2001-05-23
Abstract: A litter box including a housing for disposing therein litter for use by a pet, and a grinder for grinding excreta found in the litter box. The litter box preferably includes litter substantially impervious to grinding by the grinder. The litter box includes a filtering assembly for filtering the excreta, ground by the grinder, from the litter. The litter box preferably includes a cleansing liquid which is in fluid communication with the litter, Wherein the grinder agitates the litter and the cleansing liquid so as to cause cleansing of the litter.
Patent IL-143461-A0 (IL)
Title: Extrusion moulded facade panel
Inventor: GERHAHER FRANZ
IPC: E04F13/18
Filed: 2001-05-30
Abstract: The extruded facing panel consists of a front and rear shell(12,13), and the height(17) of the top rebate(16) formed by the rear panel shell(13) is less than or the same as the height of the join(19) visible from the front side(18) of the facing. The height of the bottom rebate formed by the front panel shell is less than or the same as the height of the join visible from the rear side of the facing. The top rebate is formed by the extension of the rear panel shell, and the bottom rebate is formed by the extension of the front panel shell.
Patent IL-145087-A0 (IL)
Title: A means for the prophylactic and therapeutic treatment of streptococcal infections
IPC: A61K47/34
Filed: 1999-02-25
Abstract: Biodegradable polymer compositions suitable for intraperitoneal administration to treat a mammalian subject having ovarian cancer are described, wherein the polymer compositions provide extended release of the antineoplastic agent into the peritoneum of the subject. The subject compositions can increase the median survival rate from the cancer by at least about 10%, as compared with the median survival rate obtained by administration of a composition comprising the same dosage of the antineoplastic agent without the biodegradable polymer. Solid articles and methods for treating ovarian cancer are also described.
Patent IL-157140-A0 (IL)
Title: Mixture of bacillus thuringiensis subspecies israelensis and bacillus sphaericus for management of resistance to mosquito larvicides
IPC: A01N63/23
Filed: 2002-02-13
Abstract: A method for controlling Dipteran larvae or a method for inhibiting the development of larvicidal resistance, controlling resistant populations and reducing resistance levels in Diptera by introducing a larvicidally-effective amount of a combination of a strain of Bacillus thuringiensis subspecies israelensis and a strain of Bacillus sphaericus into an environment containing Dipteran larvae; and a composition of the combination are disclosed. Preferably both strains are non-genetically modified.
Patent IL-157415-A0 (IL)
Title: Supersecretable peptides, processes for their production, and parallel improvement of the secreted form of one or more other polypeptides
IPC: C12N15/81
Filed: 2002-02-08
Abstract: The invention relates to an expression cassette of the form Px-Sx-Bn-(ZR)-transport peptide-(Z1Z2)-protein(Y)-(Z1Z2)-protein (Ym)-T; wherein the expression cassette codes for a transport peptide linked via a sequence Z1Z2 to a second protein which in turn is linked via Z1Z2 to a protein Y1 which either corresponds to Y or can be different from Y and the transport peptide improves the rate of secretion and Y and/or Ym where Px is any promoter DNA sequence selected in such a way that optimal yields of the protein of interest become obtainable; Sx is any DNA which, accordingly, encodes any signal or leader sequence which allows optimal yields; Bn is 1-15 genetically encodable amino acids or a chemical bond; Z is the codon of an amino acid selected from the group comprising Lys and Arg; Z1 is the codon of an amino acid selected from the group comprising Lys and Arg; Z2 is the codon of an amino acid selected from the group comprising Lys and Arg; protein Ym is a DNA sequence encoding any protein which can be produced and secreted by yeast (m=1-5) or is a chemical bon (m=0); R is an argine codon; transport peptide is a DNA sequence encoding a peptide which can be transported efficiently and which can pass membranes; protein Y is a DNA sequence encoding any protein which can be produced and secreted by yeast and whose biological activity, when Ym is not a chemical bond, is not impaired by a basic dipeptide extension or allows degradation of the extension by carboxypeptidases; T is an untranslated DNA sequence advantageous to the expression, and to processes for the production and use thereof.
Patent IL-158060-A0 (IL)
Title: Use of cd25 binding molecules in steroid-resistant patients
IPC: A61P9/14
Filed: 2002-04-05
Abstract: A method for the treatment of a disease selected from the group consisting of autoimmune hepatitis, eczema, vasculitis, temporal arteritis, sarcoid and Crohn's disease, in a steroid-resistant or steroid-sensitive patient, comprising administering to the patient in an effective amount of a CD25 binding molecule.
Patent IL-175407-A0 (IL)
Title: Use of thiazolidine or pyrrolidine derivatives of amino acids for producing antihyperglymetic pharmaceutical compositions
IPC: C07K5/06
Filed: 2006-05-04
Abstract: Valyl-thiazolidide (Ia), valyl-pyrrolidide (Ib), and salts of these, are new.
Patent IL-186290-A0 (IL)
Title: Liquid drug delivery devices for use with syringe having widened distal tip
Filed: 2007-09-25
Abstract: Liquid drug delivery device includes a housing with a syringe port for sealingly receiving a syringe having a syringe tip ending at a widened distal tip, a vial adapter port with a vial adapter for snap fit receiving a vial, and a drug administration port for administering a liquid drug. The vial adapter is intended to be rotationally detached after a mixing procedure for discarding together with a spent vial. The syringe port additionally includes a single use locking mechanism for securing the syringe to preclude inadvertent syringe detachment under normal use including agitation for reconstitution purposes. The drug administration port has a distal tip preferably similar to a syringe's widened distal tip for the same purpose of preventing conventional needles with a female Luer connector being slidingly mounted thereon.
Patent IL-189267-A0 (IL)
Title: Azole and thiazole derivatives and their use
IPC: C07D413/06
Filed: 2008-02-04
Abstract: Pharmaceutical compositions for inhalation comprising compounds of formula (I) are useful in the treatment of diseases where enhanced M3 receptor activation is implicated, such as respiritory tract diseases:   
wherein (i)  R 1   is C 1 -C 6 -alkyl or hydrogen; and  R 2   is hydrogen or a group -R 7 , -Z-Y-R 7 , 
-Z-NR 9 R 10 ; -Z-CO-NR 9 R 10 , -Z-NR 9 -C(O)O-R 7 , or -Z-C(O)-R 7 ; and  R 3   is a lone pair, or C 1 -C 6 -alkyl; or (ii)  R 1   and  R 3   together with the nitrogen to which they are attached form a heterocycloalkyl ring, and  R 2   is a lone pair or a group -R 7 , -Z-Y-R 7 , -Z-NR 9 R 10 , 
-Z-CO-NR 9 R 10 , -Z-NR 9 -C(O)O-R 7 ; or; -Z-C(O)-R 7 ; or (iii)  R 1  and R 2   together with the nitrogen to which they are attached form a heterocycloalkyl ring, said ring being substituted by a group -Y-R 7 , -Z-Y-R 7 , -Z-NR 9 R 10 ; -Z-CO-NR 9 R 10 ; -Z-NR 9 -C(O)OR 7 ; or; -Z-C(O)-R 7 ; and  R 3   is a lone pair, or C 1 -C 6 -alkyl;  R 4   and  R 5   are independently selected from the group consisting of aryl, aryl-fused-heterocycloalkyl, heteroaryl, C 1 -C 6 -alkyl, cycloalkyl;  R 6   is -OH, C 1 -C 6 -alkyl, C 1 -C 6 -alkoxy, hydroxy-C 1 -C 6 -alkyl, nitrile, a group CONR 8  2  or a hydrogen atom;  A  is an oxygen or a sulfur atom;  X  is an alkylene, alkenylene or alkynylene group;  R 7   is an C 1 -C 6 -alkyl, aryl, aryl-fused-cycloalkyl, aryl-fused-heterocycloalkyl, heteroaryl, aryl(C 1 -C 8 -alkyl)-, heteroaryl(C 1 -C 8 -alkyl)-, cycloalkyl or heterocycloalkyl group;  R 8   is C 1 -C 6 -alkyl or a hydrogen atom;  Z  is a C 1 -C 16 -alkylene, C 2 -C 16 -alkenylene or C 2 -C 16 -alkynylene group;  Y  is a bond or oxygen atom;  R 9   and  R 10   are independently a hydrogen atom, C 1 -C 6 -alkyl, aryl, aryl-fused-heterocycloalkyl, aryl-fused-cycloalkyl, heteroaryl, aryl(C 1 -C 6 -alkyl)-, or heteroaryl(C 1 -C 6 -alkyl)- group; or  R 9   and  R 10   together with the nitrogen atom to which they are attached form a heterocyclic ring of 4-8 atoms, optionally containing a further nitrogen or oxygen atom.
Patent IL-196085-A0 (IL)
Title: Cyclic amine compounds and pharmaceutical compositions containing the same
Filed: 2008-12-21
Abstract: The present invention provides an excellent antihypertensive medicament. The medicament of the present invention comprises a compound having the general formula (I) and the like:   
[wherein R 1 : H, substitutable alkyl, substitutable alkenyl, substitutable cyclic hydrocarbon, substitutable heterocyclyl or the like; R 2 : H, substitutable alkyl, substitutable alkenyl, substitutable cycloalkyl or the like; R 3 , R 4 ; H, substitutable alkyl, substitutable alkenyl, substitutable cycloalkyl or the like; R 5 , R 6 : H, substitutable alkyl, substitutable cycloalkyl, substitutable alkoxy or the like; R 7 , R 8 : H, substitutable alkyl, substitutable cycloalkyl or the like; X: the formula (II) or the like; A: substitutable cyclic hydrocarbon, substitutable heterocyclyl or the like; Y: a single bond, substitutable alkylene, substitutable alkenylene, -(CH 2 ) a -X 1 -(CH 2 ) b - (X 1 : the formula -NH-, -O- or the like; a, b: 0-5) or the like; B: substitutable cyclic hydrocarbon, substitutable heterocyclyl or the like].
Patent IL-201325-A0 (IL)
Title: Automatic liquid drug preparation apparatus for the preparation of a predetermined dosage of liquid drug
Filed: 2009-10-01
Abstract: Automatic liquid drug preparation apparatus for preparing a liquid drug assemblage with a predetermined dosage of liquid drug. The liquid drug assemblage is prepared from a preparatory assemblage including a fluid control device having a body member with a syringe port, a vial adapter, and an administration port, a vial pre-filled with powder or liquid medicament, and a syringe pre-filled with diluent for mixing with the medicament. The automatic liquid drug preparation apparatus includes a housing, a cradle for receiving the preparatory assemblage, and a controller for controlling a motorized syringe drive unit for selectively transferring liquid contents between the syringe and the vial, a motorized cradle drive unit for selectively rotating the cradle relative to the housing, and a motorized vial adapter release unit for selectively detaching the vial adapter with its attached spent vial from the body member to form the liquid drug assemblage.
Patent RO-132826-A0 (RO)
Title: Plant for non-stop water-based renewable electric power production without polluting-fuel consumption
Inventor: TUDOR ION
IPC: F03B13/14
Filed: 2018-05-17
Abstract: The invention relates to a plant for non-stop water-based renewable electric power production which is sufficient for the operation of dwelling houses, such as individual houses or holiday cottages, chalets or guest houses. According to the invention, the plant consists of a water basin (1) and a chain and buckets installation, a speed regulator (20), a braking installation (21) and some anchors (23) for fixing it onto the concrete foundation where a metal frame (3) of rectangular cross-section and a height H of the chain and buckets installation is mounted with some screws (2), where piping of rectangular cross-section of the metal frame (3) is provided therein, at the two ends there being an upper shaft (4) comprising two chain wheels (5) mounted by means of some upper bearing boxes (6) and a lower shaft (7) fixed with some sliding bearing boxes (8), provided with two tighteners (9), two parallel chains (10) moving on each of the two shafts, and, on the said chains (10) there being some buckets (11) of trapeze-shaped cross-section, having a cover (12) and holes for the water to seep into the bucket, the cover being attached by means of some hinges (13) and acting by gravity, closed upon getting down and open upon getting up, where, after returning to the top part, two side cams (24) maintain the cover (12) open at 0.5 mm, for the buckets to be filled, the frame (3) having at the top part a water supply orifice (15) and, at the bottom part, a water discharge slot (16) at the bottom and a pump (17) mounted laterally, at a height of 8 mm, meant to suck in the water and lift it to a height of 17 m, it being coupled along the shaft (4) with a generator (18), by means of a resilient coupling (19), the water being pumped from the basin (1) by means of the pump (17), through the orifice (15), the buckets (11) being this way filled with water, the column of buckets filled with water being then emptied, the water getting through the slot (16) into the basin wherefrom it is pumped and its lifting is resumed.
Patent RO-135604-A0 (RO)
Title: Advanced system for actively controlling the optimal operating temperature of photovoltaic solar panels
Inventor: DOGEANU ANGEL MĂDĂLIN
IPC: F24D17/00
Filed: 2021-11-15
Abstract: The invention relates to an advanced system for actively controlling the optimum operating temperature of solar photovoltaic panels. According to the invention, the system for reducing the surface temperature of solar voltaic panels consists in carrying out two modules, namely a discharge module (1) and a control system (2), the discharge device being made of a tube provided with 50 mm-long and 3 mm-wide slots, arranged at a distance of 25 mm from each other, the circulation of the air used as a cooling medium being carried out by means of a fan supplied with direct current, connected to the discharge device by means of a removable flange for maintenance and cleaning, the air being taken over from the outside by means of a detachable air intake module, and the control system consisting of a micro-controller located in a sealed dose, mounted on the inner face of the solar panel, a control system being necessary for each row of panels, the control being performed using two digital temperature sensors located as follows: a temperature sensor placed at 10 cm from the top of the solar panels for reading the surface temperature and the second sensor placed on the fan air intake for reading the temperature of the air used for forced convection, the controller being meant to control the fan supply and the variation of its speed in accordance with the control function implemented in it, the power supply of the fans being made in direct current, to benefit from the energy produced by the solar panels, and the micro-controller being meant to adjust the fan speed and, implicitly, its consumption depending on the temperatures read by those two sensors keeping the power consumption of the fan below the value of the additional output obtained.
Patent AP-2001002243-A0 (AP)
Title: Automated transcription system and method using two speech converting instances and computer-assisted correction.
Inventor: KAHN JONATHAN
IPC: G10L15/28
Filed: 2000-02-18
Abstract: A system for substancially automating transcription services for one or more voice users is disclosed. This system receives a voice dictation file from a current user,which is automatically converting into a first written text based on a first set of conversion variables. The same voice dictation file is automatically converted into a second written text based on a second set of conversion variables. The first and second sets of conversionsuch as different speech recognition programs, different vocabularies, and the like. The system further includes a program for manually editing a copy of the first and second written texts to create a verbatim text of the voice dictation file (40). This verbatim text can then be delivered to the the current user as transcribed text. The verbatim text can also be fed back into each speech recogntion instance toward improving the accuracy of each instance with respect to the human voice in the file.